The Research Triangle Park

The future of great ideas

a seminar held at Research Triangle Park

Events Calendar

Life ScienceBusinessNetworking

Biotech Forum

Date

10/5/2011

Time

5:00 PM - 8:00 PM

Organization/Sponsor

CED | NC Biotech Center | Deloitte | Clinipace

Description

The recent rise in option deals has been driven at least in part by the lack of financing or exit alternatives. According to seasoned dealmakers, they are not just a short-term symptom of a buyers’ market, but potentially a viable opportunity for biotechs to partner with deep-pocketed pharma companies. Come out to the next Biotech Forum and hear seasoned biopharma dealmakers from GSK, Eli Lilly, and Novartis Option Fund discuss option based deals. How do they work and how can a startup benefit from one?

Speakers:

  • David Donabedian, VP, Business Development, Alternative Discovery & Development, GSK
  • Mark A. Miller, VP of Corporate Business Development, Eli Lilly and Company
  • Lauren Silverman, Managing Director, Novartis Option Fund
  • Paul Torrey, Life Sciences Industry Practice, Deloitte

Registration Status

Location

North Carolina Biotechnology Center
15 T.W. Alexander Drive
Research Triangle Park, NC 27713

Driving Directions